Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Andreas Hüttmann

FB Medizin, Universitätsklinikum Essen, Klinik für Hämatologie und Stammzelltransplantation

Anschrift
Hufelandstraße 55
45147 Essen
Telefon
0201 723 1861
Telefax
0201 723 1891
E-Mail
andreas.huettmann@uni-due.de
Webseite
https://www.uni-essen-haematologie.de/

Funktionen

  • , Klinik für Hämatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Dührsen, Ulrich; Prange-Krex, Gabriele; Moeller, Regina; Held, Harald; Heil, Gerhard; Schwarzer, Andreas; Mahlmann, Stefan; Dienst, Ariane; Sandmann, Matthias; Maschmeyer, Georg; Schütte, Jochen; Hahn, Dennis; Heike, Michael; Nonnemacher, Michael; Hanoun, Christine; Hüttmann, Andreas; PETAL trial investigators
    Health-related quality of life in patients with aggressive non-Hodgkin lymphoma : results from the PETAL trial
    In: Annals of Hematology , Jg. 104 2025, Nr. 5, S. 2831 – 2845
    DOI (Open Access)
  • Mendeville, Matías S.; Janssen, Jurriaan; Los-de Vries, G. Tjitske; van Dijk, Erik; Richter, Julia; Nijland, Marcel; Roemer, Margaretha G. M.; Stathi, Phylicia; Hijmering, Nathalie J.; Bladergroen, Reno; Pelaz, Diego A.; Diepstra, Arjan; Eertink, Corinne J.; Burggraaff, Coreline N.; Kim, Yongsoo; Lugtenburg, Pieternella J.; van den Berg, Anke; Tzankov, Alexandar; Dirnhofer, Stefan; Dührsen, Ulrich; Hüttmann, Andreas; Klapper, Wolfram; Zijlstra, Josée M.; Ylstra, Bauke; de Jong, Daphne
    Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma
    In: Nature Communications , Jg. 16 2025, Nr. 1, 109
    DOI (Open Access)
  • Fuhrmann, Stephan; Nickelsen, Maike; Hasenkamp, Justin; Hüttmann, Andreas; Dreyling, Martin; Kiehl, Michael; Salwender, Hans; Placzek, Marius; Hilgers, Reinhard; Schmitz, Norbert; Glass, Bertram
    Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma : an open-label, multicentre phase I/II study (DSHNHL-R6)
    In: Annals of Hematology , Jg. 104 2025, Nr. 4, S. 2317 – 2325
    DOI (Open Access)
  • Borchmann, Peter; Ferdinandus, Justin; Schneider, Gundolf; Moccia, Alden; Greil, Richard; Hertzberg, Mark; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Dierlamm, Judith; Hänel, Mathias; Novak, Urban; Meissner, Julia; Zimmermann, Andreas; Mathas, Stephan; Zijlstra, Josée M; Fosså, Alexander; Viardot, Andreas; Hertenstein, Bernd; Martin, Sonja; Giri, Pratyush; Scholl, Sebastian; Topp, Max S; Jung, Wolfram; Vucinic, Vladan; Beck, Hans-Joachim; Kerkhoff, Andrea; Unger, Benjamin; Rank, Andreas; Schroers, Roland; zum Büschenfelde, Christian Meyer; de Wit, Maike; Trautmann-Grill, Karolin; Kamper, Peter; Molin, Daniel; Kreissl, Stefanie; Kaul, Helen; von Tresckow, Bastian; Borchmann, Sven; Behringer, Karolin; Fuchs, Michael; Rosenwald, Andreas; Klapper, Wolfram; Eich, Hans-Theodor; Baues, Christian; Zomas, Athanasios; Hallek, Michael; Dietlein, Markus; Kobe, Carsten; Diehl, Volker
    Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21) : a randomised, multicentre, parallel, open-label, phase 3 trial
    In: Lancet , Jg. 404 2024, Nr. 10450, S. 341 – 352
    DOI (Open Access)
  • Martelli, Maurizio; Ceriani, Luca; Ciccone, Giovannino; Ricardi, Umberto; Kriachok, Iryna; Botto, Barbara; Balzarotti, Monica; Tucci, Alessandra; Usai, Sara Veronica; Zilioli, Vittorio Ruggero; Pennese, Elsa; Arcaini, Luca; Dabrowska-Iwanicka, Anna; Ferreri, Andrés J.M.; Merli, Francesco; Zhao, Weili; Rigacci, Luigi; Cellini, Claudia; Hodgson, David; Ionescu, Codruta; Minoia, Carla; Lucchini, Elisa; Spina, Michele; Fosså, Alexander; Janikova, Andrea; Cwynarski, Kate; Mikhaeel, George; Jerkeman, Mats; Di Rocco, Alice; Stepanishyna, Yana; Vitolo, Umberto; Santoro, Armando; Re, Alessandro; Puccini, Benedetta; Olivieri, Jacopo; Petrucci, Luigi; Barrington, Sally F.; Malkowski, Bogdan; Metser, Ur; Versari, Annibale; Chauvie, Stephane; Walewski, Jan; Trneny, Marek; Cavalli, Franco; Gospodarowicz, Mary; Johnson, Peter W.M.; Davies, Andrew; Zucca, Emanuele; Kuruvilla, John; Wang, Li; Balada, David; Mocikova, Heidi; Hüttmann, Andreas; Angrilli, Francesco; Annibali, Ombretta; Arcaini, Luca; Bagni, Oreste; Battistini, Roberta; Cabras, Maria Giuseppina; Calimeri, Teresa; Catello, Califano; Cavallo, Federica; Ciammella, Patrizia; Consoli, Ugo; De Sanctis, Vitaliana; Di Renzo, Nicola; Fabbri, Alberto; Ferrari, Angela; Flenghi, Leonardo; Gaidano, Gianluca; Gini, Guido; Gotti, Manuel; Guarini, Attilio; Liberati, Anna Marina; Mannina, Donato; Matrone, Fabio; Molinari, Anna Lia; Musuraca, Gerardo; Nassi, Luca; Passamonti, Francesco; Pastore, Domenico; Patti, Caterina; Pelliccia, Sabrina; Piazza, Francesco; Pisani, Francesco; Pizzuti, Michele; Pozzi, Samantha; Ravano, Emanuele; Re, Francesca; Sassone, Marianna; Stefoni, Vittorio; Stelitano, Caterina; Tarantini, Giuseppe; Tarella, Corrado; Vallisa, Daniele; Zaja, Francesco; Zanni, Manuela; Fagerli, Un Merete; DaSilva, Maria Gomes; Azinwi, Ngwa Che; Deantonio, Letizia; Hitz, Felicitas; Mingrone, Walter; Moccia, Alden; Novak, Urban; Pirosa, Maria Cristina; Stathis, Anastasios; Cozens, Kelly; Fox, Christopher P.; Illidge, Timothy; Johnson, Rod; McKay, Pam; Milne, Alison; Nimish, Shah; Osborne, Wendy; Paneesha, Shankara; Pettitt, Andrew; Stevens, Don Ambrose; Bonomini, Luisella; Ielmini, Nicoletta
    Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma : IELSG37 Trial Results
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. 34, S. 4071 – 4083
    DOI
  • Dührsen, Ulrich; Bockisch, Andreas; Hertenstein, Bernd; Karsten, Imke E.; Kroschinsky, Frank; Heuser, Michael; Hochhaus, Andreas; Höffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Tometten, Mareike; Grieshammer, Martin; Grigoleit, Götz U.; Schmalz, Oliver; Jordan, Karin; Bernhard, Helga; Gaska, Tobias; Giagounidis, Aristoteles; Schroers, Roland; Martens, Uwe M.; Held, Gerhard; Klapper, Wolfram; Jöckel, Karl-Heinz; Nonnemacher, Michael; Hüttmann, Andreas
    Response-guided first-line therapy and treatment of relapse in aggressive lymphoma : 10-year follow-up of the PETAL trial
    In: Blood Neoplasia , Jg. 1 2024, Nr. 3, 100018
    DOI, Online Volltext (Open Access)
  • Camus, Vincent; Thieblemont, Catherine; Gaulard, Philippe; Cheminant, Morgane; Casasnovas, Rene-Olivier; Ysebaert, Loïc; Damaj, Gandhi Laurent; Guidez, Stéphanie; Pica, Gian Matteo; Kim, Won Seog; Lim, Soon Thye; Andre, Marc; Gutiérrez, Norma; Penarrubia, Maria Jesus; Staber, Philipp B.; Trotman, Judith; Hüttmann, Andreas; Stefoni, Vittorio; Tucci, Alessandra; Fogarty, Patrick; Farhat, Hassan; Abraham, Julie; Abarah, Wajed; Belmecheri, Fatiha; Ribrag, Vincent; Delfau-Larue, Marie-Helene; Cottereau, Anne-Ségolène; Itti, Emmanuel; Li, Ju; Delarue, Richard; de Leval, Laurence; Morschhauser, Franck; Bachy, Emmanuel
    Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma : Final Analysis of the Ro-CHOP Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. 14, S. 1612 – 1618
    DOI (Open Access)
  • Ferrández, Maria C.; Golla, Sandeep S.V.; Eertink, Jakoba J.; Wiegers, Sanne E.; Zwezerijnen, Gerben J.C.; Heymans, Martijn W.; Lugtenburg, Pieternella J.; Kurch, Lars; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; Barrington, Sally F.; Mikhaeel, N. George; Ceriani, Luca; Zucca, Emanuele; Czibor, Sándor; Györke, Tamás; Chamuleau, Martine E.D.; Zijlstra, Josée M.; Boellaard, Ronald
    Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma
    In: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 11, S. 1802 – 1807
    DOI
  • Ferrández, Maria C.; Golla, Sandeep S. V.; Eertink, Jakoba J.; de Vries, Bart M.; Lugtenburg, Pieternella J.; Wiegers, Sanne E.; Zwezerijnen, Gerben J. C.; Pieplenbosch, Simone; Kurch, Lars; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; de Vet, Henrica C. W.; Josée M., Zijlstra; Ronald, Boellaard
    An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
    In: Scientific Reports , Jg. 13 2023, Nr. 1, 13111
    DOI (Open Access)
  • Eertink, J.J.; Zwezerijnen, G.J.C.; Heymans, M.W.; Pieplenbosch, S.; Wiegers, S.E.; Dührsen, U.; Hüttmann, Andreas; Kurch, L.; Hanoun, C.; Lugtenburg, P.J.; Barrington, S.F.; Mikhaeel, N.G.; Ceriani, L.; Zucca, E.; Czibor, S.; Györke, T.; Chamuleau, M.E.D.; Hoekstra, O.S.; de Vet, H.C.W.; Boellaard, R.; Zijlstra, J.M.; Eertink, Jakoba Johanna; Zwezerijnen, Gerben JC; Heymans, Martijn; Wiegers, Sanne Elisabeth; Lugtenburg, Pieternella J.; Barrington, Sally; Mikhaeel, N. George; Chamuleau, Martine E.D.; Hoekstra, Otto S; De Vet, Henrica CW; Zijlstra, Josée M.
    Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
    In: Blood , Jg. 141 2023, Nr. 25, S. 3055 – 3064
    DOI (Open Access)
  • Zwezerijnen, Gerben J.C.; Wiegers, Sanne E.; Pieplenbosch, Simone; Chamuleau, Martine E.D.; Lugtenburg, Pieternella J.; de Jong, Daphne; Ylstra, Bauke; Mendeville, Matias; Dührsen, Ulrich; Hanoun, Christine; Hüttmann, Andreas; Richter, Julia; Klapper, Wolfram; Jauw, Yvonne W.S.; Hoekstra, Otto S.; de Vet, Henrica C.W.; Boellaard, Ronald; Zijlstra, Josée M.; Eertink, Jakoba Johanna; Eertink, Jakoba Johanna
    Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
    In: Blood Advances , Jg. 7 2023, Nr. 2, S. 214 – 223
    DOI (Open Access)
  • Sworder, Brian J.; Kurtz, David M.; Alig, Stefan K.; Frank, Matthew J.; Shukla, Navika; Garofalo, Andrea; Macaulay, Charles W.; Shahrokh Esfahani, Mohammad; Olsen, Mari N.; Hamilton, James; Hosoya, Hitomi; Hamilton, Mark; Spiegel, Jay Y.; Baird, John H.; Sugio, Takeshi; Carleton, Mia; Craig, Alexander F.M.; Younes, Sheren F.; Sahaf, Bita; Sheybani, Natasha D.; Schroers-Martin, Joseph G.; Liu, Chih Long; Oak, Jean S.; Jin, Michael C.; Beygi, Sara; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; Westin, Jason R.; Khodadoust, Michael S.; Natkunam, Yasodha; Majzner, Robbie G.; Mackall, Crystal L.; Diehn, Maximilian; Miklos, David B.; Alizadeh, Ash A.
    Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
    In: Cancer Cell , Jg. 41 2023, Nr. 1, S. 210 – 225.e5
    DOI (Open Access)
  • Hoffmann, Christian; Ringbaek, Toke; Eckstein, Anja; Deya, Wolfgang; Santiago, Alina; Heintz, Martin; Lübcke, Wolfgang; Indenkämpen, Frank; Sauerwein, Wolfgang; Flühs, Andrea; Le Guin, Claudia; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia; Deuschl, Cornelius; Moliavi, Sourour; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Johansson, Patricia; Bechrakis, Nikolaos; Stuschke, Martin; Guberina, Maja
    Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy : Results from a Longitudinal Study
    In: Cancers , Jg. 15 2023, Nr. 22, 5433
    DOI (Open Access)
  • Hoffmann, Christian; Mohr, Christopher; Johansson, Patricia; Eckstein, Anja; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia Luise; Deuschl, Cornelius; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Bechrakis, Nikolaos; Stuschke, Martin; Guberina, Maja
    MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kinetics
    In: Scientific Reports , Jg. 13 2023, Nr. 1, 4792
    DOI, Online Volltext (Open Access)
  • Friese, Christina; Breuckmann, Katharina; Hüttmann, Andreas; Eisele, Lewin; Dührsen, Ulrich
    Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditions
    In: Mycoses , Jg. 66 2023, Nr. 6, S. 505 – 514
    DOI (Open Access)
  • Johansson, Patricia; Alig, Stefan; Richter, Julia; Hanoun, Christine; Rekowski, Jan; Dürig, Jan; Ylstra, Bauke; de Jong, Daphne; Klapper, Wolfram; Alizadeh, Ash A.; Dührsen, Ulrich; Hüttmann, Andreas
    Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
    In: Annals of Hematology , Jg. 102 2023, Nr. 12, S. 3445 – 3455
    DOI (Open Access)
  • Fischer, Luca; Jiang, Linmiao; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Hüttmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva
    The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma : A pooled trials analysis
    In: Annals of Hematology , Jg. 102 2023, Nr. 10, S. 2791 – 2801
    DOI (Open Access)
  • Hess, Georg; Hüttmann, Andreas; Witzens‐Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias; Lenz, Georg
    A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma : Final results of the prospective, multicentre GOAL trial
    In: British Journal of Haematology , Jg. 198 2022, Nr. 3, S. 482 – 491
    DOI (Open Access)
  • Thieblemont, Catherine; Chartier, Loic; Dührsen, Ulrich; Vitolo, Umberto; Barrington, Sally F.; Zaucha, Jan M.; Vercellino, Laetitia; Silva, Maria Gomes; Patrocinio-Carvalho, Ines; Decazes, Pierre; Viailly, Pierre-Julien; Tilly, Herve; Berriolo-Riedinger, Alina; Casasnovas, Oliver; Hüttmann, Andreas; Ilyas, Hajira; Mikhaeel, N. George; Dunn, Joel; Cottereau, Anne-Ségoléne; Schmitz, Christine; Kostakoglu, Lale; Paulson, Joseph N.; Nielsen, Tina; Meignan, Michael
    A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
    In: Blood Advances , Jg. 6 2022, Nr. 23, S. 5995 – 6004
    DOI (Open Access)
  • Sasse, Stephanie; Bröckelmann, Paul Jan; Momotow, Jesko; Plütschow, Annette; Hüttmann, Andreas; Basara, Nadezda; Koenecke, Christian; Martin, Sonja; Bentz, Martin; Grosse-Thie, Christina; Thorspecken, Sven; de Wit, Maike; Kobe, Carsten; Dietlein, Markus; von Tresckow, Bastian; Fuchs, Michael; Borchmann, Peter; Engert, Andreas
    AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma : final results of an open-label, randomized, multicenter phase II trial
    In: Leukemia and Lymphoma 2022
    DOI
  • Greuter, M.J.E.; Eertink, J.J.; Jongeneel, G.; Dührsen, U.; Hüttmann, Andreas; Schmitz, C.; Lugtenburg, P.J.; Barrington, S.F.; Mikhaeel, N.G.; Ceriani, L.; Zucca, E.; Carr, R.; Györke, T.; Burggraaff, C.N.; de Vet, H.C.W.; Hoekstra, O.S.; Zijlstra, J.M.; Coupé, V.M.H.
    Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 22 2022, Nr. 6, S. 382 – 392
    DOI (Open Access)
  • Koch, Karoline; Richter, Julia; Hanel, Christoph; Hüttmann, Andreas; Dührsen, Ulrich; Klapper, Wolfram
    Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation
    In: Haematologica / The Hematology Journal , Jg. 107 2022, Nr. 9, S. 2144 – 2153
    DOI (Open Access)
  • Denker, Sophy; Bittner, Aitomi; Frick, Mareike; Kase, Julia; Hoffmann, Jörg; Trenker, Corinna; Keller, Ulrich; Bogner, Christian; Hüttmann, Andreas; Dürig, Jan; Janz, Martin; Mathas, Stephan; Marks, Reinhard; Krohn, Ulrike; Na, Il-Kang; Bullinger, Lars; Schmitt, Clemens A.
    Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma : First analysis of toxicity and efficacy signals
    In: Leukemia and Lymphoma , Jg. 63 2022, Nr. 1, S. 84 – 92
    DOI (Open Access)
  • Bröcker-Preuß, Martina; Becher-Boveleth, Nina; Müller, Stefan P.; Hüttmann, Andreas; Hanoun, Christine; Grafe, Hong; Richter, Julia; Klapper, Wolfram; Rekowski, Jan; Bockisch, Andreas; Dührsen, Ulrich
    Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma : Results from the PETAL trial
    In: Journal of Cancer Research and Clinical Oncology , Jg. 148 2022, Nr. 10, S. 2611 – 2621
    DOI (Open Access)
  • Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Hüttmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter; Lehmann, Clara
    Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma
    In: Infection - A Journal of Infectious Disease , Jg. 50 2022, Nr. 4, S. 925 – 932
    DOI (Open Access)
  • Seifert, Robert; Kersting, David; Rischpler, Christoph; Sandach, Patrick; Ferdinandus, Justin; Fendler, Wolfgang; Rahbar, Kambiz; Weckesser, Matthias; Umutlu, Lale; Hanoun, Christine; Hüttmann, Andreas; Reinhardt, Hans Christian; von Tresckow, Bastian; Herrmann, Ken; Dührsen, Ulrich; Schäfers, Michael
    Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trial
    In: Leukemia , Jg. 36 2022, Nr. 12, S. 2845 – 2852
    DOI (Open Access)
  • Hoffmann, Christian; Rating, Philipp; Bechrakis, Nikolaos; Eckstein, Anja; Sokolenko, Ekaterina; Jabbarli, Leyla; Westekemper, Henrike; Mohr, Christopher; Schmeling, Claus; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia Luise; Deuschl, Cornelius; Johansson, Patricia; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Stuschke, Martin; Guberina, Maja
    Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal study
    In: Hematological Oncology , Jg. 40 2022, Nr. 5, S. 922 – 929
    DOI (Open Access)
  • Kadow, Stephanie; Schumacher, Fabian; Kramer, Melanie; Hessler, Gabriele; Scholtysik, René; Oubari, Sara; Johansson, Patricia; Hüttmann, Andreas; Reinhardt, Hans Christian; Kleuser, Burkhard; Zoratti, Mario; Mattarei, Andrea; Szabò, Ildiko; Gulbins, Erich; Carpinteiro, Alexander
    Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
    In: Cancers , Jg. 14 2022, Nr. 8, 1955
    DOI, Online Volltext (Open Access)
  • Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Hahn, Dennis; Schroers, Roland; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Boger, Regina; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M.; Krüger, William; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ullrich, Kathleen; Griesinger, Frank; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.
    Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma : A German Hodgkin Study Group multicentre real-world analysis
    In: British Journal of Haematology , Jg. 198 2022, Nr. 2, S. 401 – 404
    DOI (Open Access)
  • Mikhaeel, N George; Heymans, Martijn W.; Eertink, Jakoba J.; de Vet, Henrica C W; Boellaard, Ronald; Dührsen, Ulrich; Ceriani, Luca; Schmitz, Christine; Wiegers, Sanne E.; Hüttmann, Andreas; Lugtenburg, Pieternella J.; Zucca, Emanuele; Zwezerijnen, Gerben J C; Hoekstra, Otto S.; Zijlstra, Josée M; Barrington, Sally F.
    Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma : International Metabolic Prognostic Index
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 21, S. 2352 – 2360
    DOI (Open Access)
  • Gillessen, Sarah; Hüttmann, Andreas; Vucinic, Vladan; Müller, Horst; Plütschow, Annette; Viardot, Andreas; Topp, Max S.; Kobe, Carsten; Böll, Boris; Eichenauer, Dennis A.; Sasse, Stephanie; Haverkamp, Heinz; Schmitz, Christine; Borchmann, Sven; Bröckelmann, Paul J.; Heger, Jan-Michel; Fuchs, Michael; Engert, Andreas; Borchmann, Peter; von Tresckow, Bastian
    Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma : An experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)
    In: British Journal of Haematology , Jg. 196 2022, Nr. 3, S. 606 – 616
    DOI (Open Access)
  • Bachy, Emmanuel; Camus, Vincent; Thieblemont, Catherine; Sibon, David; Casasnovas, René-Olivier; Ysebaert, Loïc; Damaj, Gandhi; Guidez, Stéphanie; Pica, Gian Matteo; Kim, Won Seog; Lim, Soon Thye; André, Marc; García-Sancho, Alejandro Martín; Penarrubia, Maria Jesus; Staber, Philipp B.; Trotman, Judith; Hüttmann, Andreas; Stefoni, Vittorio; Re, Alessandro; Gaulard, Philippe; Delfau-Larue, Marie-Helene; de Leval, Laurence; Meignan, Michel; Li, Ju; Morschhauser, Franck; Delarue, Richard
    Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma : Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 3, S. 242 – 251
    DOI
  • Horwitz, S.; O'Connor, O.A.; Pro, B.; Trümper, L.; Iyer, S.; Advani, R.; Bartlett, N.L.; Christensen, J.H.; Morschhauser, F.; Domingo-Domenech, E.; Rossi, G.; Kim, W.S.; Feldman, T.; Menne, T.; Belada, D.; Illés, Á.; Tobinai, K.; Tsukasaki, K.; Yeh, S.-P.; Shustov, A.; Hüttmann, Andreas; Savage, K.J.; Yuen, S.; Zinzani, P.L.; Miao, H.; Bunn, V.; Fenton, K.; Fanale, M.; Puhlmann, M.; Illidge, T.
    The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
    In: Annals of Oncology , Jg. 33 2022, Nr. 3, S. 288 – 298
    DOI (Open Access)
  • Kurtz, David M.; Soo, Joanne; Co Ting Keh, Lyron; Alig, Stefan; Chabon, Jacob J.; Sworder, Brian J.; Schultz, Andre; Jin, Michael C.; Scherer, Florian; Garofalo, Andrea; Macaulay, Charles W.; Hamilton, Emily G.; Chen, Binbin; Olsen, Mari; Schroers-Martin, Joseph G.; Craig, Alexander F. M.; Moding, Everett J.; Esfahani, Mohammad S.; Liu, Chih Long; Dührsen, Ulrich; Hüttmann, Andreas; Casasnovas, René-Olivier; Westin, Jason R.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
    In: Nature Biotechnology , Jg. 39 2021, Nr. 12, S. 1537 – 1547
    DOI (Open Access)
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 48 2021, Nr. 11, S. 3550 – 3559
    DOI (Open Access)
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 48 2021, Nr. 11, S. 3550 – 3559
    DOI (Open Access)
  • Rekowski, Jan; Hüttmann, Andreas; Schmitz, Christine; Müller, Stefan P.; Kurch, Lars; Kotzerke, Jörg; Franzius, Christiane; Weckesser, Matthias; Bengel, Frank M.; Freesmeyer, Martin; Hertel, Andreas; Krohn, Thomas; Holzinger, Jens; Brink, Ingo; Haberkorn, Uwe; Nyuyki, Fonyuy; van Assema, Daniëlle M E; Geworski, Lilli; Hasenclever, Dirk; Jöckel, Karl-Heinz; Dührsen, Ulrich
    Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations : Comparison of the Deauville 5-Point Scale and the ΔSUVmₐₓ Method
    In: Journal of Nuclear Medicine (JNM) , Jg. 62 2021, Nr. 1, S. 37 – 42
    DOI (Open Access)
  • Kurch, Lars; Hüttmann, Andreas; Georgi, Thomas W.; Rekowski, Jan; Sabri, Osama; Schmitz, Christine; Kluge, Regine; Dührsen, Ulrich; Hasenclever, Dirk
    Interim PET in Diffuse Large B-Cell Lymphoma
    In: Journal of Nuclear Medicine (JNM) , Jg. 62 2021, Nr. 8, S. 1068 – 1074
    DOI (Open Access)
  • Eertink, J. J.; Burggraaff, C. N.; Heymans, M. W.; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Müller, S.; Lugtenburg, P. J.; Barrington, S. F.; Mikhaeel, N. G.; Carr, R.; Czibor, S.; Györke, T.; Ceriani, L.; Zucca, E.; Hutchings, M.; Kostakoglu, L.; Loft, A.; Fanti, S.; Wiegers, S. E.; Pieplenbosch, S.; Boellaard, R.; Hoekstra, O. S.; Zijlstra, J. M.; de Vet, H. C. W.
    Optimal timing and criteria of interim PET in DLBCL : a comparative study of 1692 patients
    In: Blood Advances , Jg. 5 2021, Nr. 9, S. 2375 – 2384
    DOI (Open Access)
  • Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; Wilhelm, Martin; Zijlstra, Josée M; Moccia, Alden; Kuhnert, Georg; Bröckelmann, Paul J; von Tresckow, Bastian; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas
    PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 22 2021, Nr. 2, S. 223 – 234
    DOI
  • Dührsen, Ulrich; Tometten, Mareike; Kroschinsky, Frank; Ganser, Arnold; Ibach, Stefan; Bertram, Stefanie; Hüttmann, Andreas
    Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma
    In: Blood Cancer Journal , Jg. 11 2021, Nr. 5, 95
    DOI (Open Access)
  • Liebers, Nora; Duell, Johannes; Fitzgerald, Donnacha; Kerkhoff, Andrea; Noerenberg, Daniel; Kaebisch, Eva; Acker, Fabian; Fuhrmann, Stephan; Leng, Corinna; Welslau, Manfred; Chemnitz, Jens; Middeke, Jan-Moritz; Weber, Thomas; Holtick, Udo; Trappe, Ralf; Pfannes, Roald; Liersch, Ruediger; Spoer, Christian; Fuxius, Stefan; Gebauer, Niklas; Caillé, Léandra; Geer, Thomas; Koenecke, Christian; Keller, Ulrich; Claus, Rainer; Mougiakakos, Dimitrios; Mayer, Stephanie; Hüttmann, Andreas; Pott, Christiane; Trummer, Arne; Wulf, Gerald; Brunnberg, Uta; Bullinger, Lars; Hess, Georg; Mueller-Tidow, Carsten; Glass, Bertram; Lenz, Georg; Dreger, Peter; Dietrich, Sascha
    Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas
    In: Blood Advances , Jg. 5 2021, Nr. 13, S. 2707 – 2716
    DOI (Open Access)
  • Kurch, Lars; Dührsen, Ulrich; Hüttmann, Andreas; Georgi, Thomas W.; Sabri, Osama; Kluge, Regine; Hasenclever, Dirk
    Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
    In: EJNMMI Research , Jg. 11 2021, Nr. 1, 90
    DOI (Open Access)
  • Alig, Stefan; Macaulay, Charles W.; Kurtz, David M.; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Jin, Michael C.; Sworder, Brian J.; Garofalo, Andrea; Shahrokh Esfahani, Mohammad; Nabet, Barzin Y.; Soo, Joanne; Scherer, Florian; Craig, Alexander F M; Casasnovas, Olivier; Westin, Jason R.; Gaidano, Gianluca; Rossi, Davide; Roschewski, Mark; Wilson, Wyndham H.; Meignan, Michel; Diehn, Maximilian; Alizadeh, Ash A.
    Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 23, S. 2605 – 2616
    DOI (Open Access)
  • Schmitz, Christine; Rekowski, Jan; Müller, Stefan; Hertenstein, Bernd; Franzius, Christiane; Ganser, Arnold; Bengel, Frank M.; Kroschinsky, Frank; Kotzerke, Jörg; La Rosée, Paul; Freesmeyer, Martin; Hoeffkes, Heinz-Gert; Hertel, Andreas; Behringer, Dirk; Mesters, Rolf; Weckesser, Matthias; Mahlmann, Stefan; Haberkorn, Uwe; Martens, Uwe; Prange-Krex, Gabriele; Brenner, Winfried; Giagounidis, Aristoteles; Moeller, Regina; Runde, Volker; Sandmann, Matthias; Hautzel, Hubertus; Wilop, Stefan; Krohn, Thomas; Dürk, Heinz; Heike, Michael; Alashkar, Ferras; Brinkmann, Marcus; Trenn, Guido; Wacker, Dietmar; Kreisel-Büstgens, Christiane; Bernhard, Helga; Heil, Gerhard; Larisch, Rolf; Kurch, Lars; Jöckel, Karl-Heinz; Hoelzer, Dieter; Klapper, Wolfram; Boellaard, Ronald; Dührsen, Ulrich; Hüttmann, Andreas
    Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial
    In: Hematological Oncology 2020
    DOI (Open Access)
  • Schmitz, Christine; Hüttmann, Andreas; Müller, Stefan; Hanoun, Maher; Boellaard, Ronald; Brinkmann, Marcus; Jöckel, Karl-Heinz; Dührsen, Ulrich; Rekowski, Jan
    Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] (European Journal of Cancer (2020) 124 (25–36), (S0959804919307555), (10.1016/j.ejca.2019.09.027))
    In: European Journal of Cancer (EJC) , Jg. 136 2020, S. 207 – 208
    DOI
  • Schmitz, Christine; Hüttmann, Andreas; Müller, Stefan; Hanoun, Maher; Boellaard, Ronald; Brinkmann, Marcus; Jöckel, Karl-Heinz; Dührsen, Ulrich; Rekowski, Jan
    Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma : Post-hoc analysis from the PETAL trial
    In: European Journal of Cancer (EJC) , Jg. 124 2020, S. 25 – 36
    DOI
  • Bröckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas
    Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma : The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial
    In: JAMA Oncology , Jg. 6 2020, Nr. 6, S. 872 – 880
    DOI (Open Access)
  • Wagner, Bettina; Dührsen, Ulrich; Hüttmann, Andreas; Nückel, Holger; Michita, Rafael Tomoya; Rohn, Hana; Schramm, Sabine; Horn, Peter; Rebmann, Vera
    Genetic Variants of the NKG2C/HLA-E Receptor : Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma
    In: Cancers , Jg. 12 2020, Nr. 11, S. 3429
    DOI, Online Volltext (Open Access)
  • Schmitz, Christine; Rekowski, Jan; Müller, Stefan; Farsijani, Navid; Hertenstein, Bernd; Franzius, Christiane; von Verschuer, Ulla; La Rosée, Paul; Freesmeyer, Martin; Wilop, Stefan; Krohn, Thomas; Raghavachar, Aruna; Ganser, Arnold; Bengel, Frank M.; Prange-Krex, Gabriele; Kroschinsky, Frank; Kotzerke, Jörg; Giagounidis, Aristoteles; Dührsen, Ulrich; Hüttmann, Andreas
    Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy
    In: Cancer Medicine , Jg. 99 2020, Nr. 22, S. 8386 – 8396
    DOI, Online Volltext (Open Access)
  • Schmitz, Christine; Rekowski, Jan; Reinke, Sarah; Müller, Stefan; Hüttmann, Andreas; Klapper, Wolfram; Dührsen, Ulrich
    Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphoma
    In: Leukemia and Lymphoma , Jg. 61 2020, Nr. 6, S. 1372 – 1379
    DOI
  • Schmitz, Christine; Hüttmann, Andreas; Müller, Stefan; Hanoun, Maher; Boellaard, Ronald; Brinkmann, Marcus; Jöckel, Karl-Heinz; Dührsen, Ulrich; Rekowski, Jan
    Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination
    In: Data in Brief , Jg. 28 2020, 104976
    DOI (Open Access)
  • Horwitz, Steven; O'Connor, Owen A.; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hüttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Iyer, Swaminathan; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Trümper, Lorenz; Aboulafia, David; Alpdogan, Onder; Ando, Kiyoshi; Arcaini, Luca; Baldini, Luca; Bellam, Naresh; Yehuda, Dina Ben; Benedetti, Fabio; Borchman, Peter; Bordessoule, Dominique; Brice, Pauline; Briones, Javier; Caballero, Dolores; Carella, Angelo Michele; Chang, Hung; Cheong, June Weon; Cho, Seok-Goo; Choi, Ilseung; Choquet, Sylvain; Colita, Andrei; Congui, Angela Giovanna; D'amore, Francesco; Dang, Nam; Davison, Kelly; Guibert, Sophie de; Brown, Peter de Nully; Delwail, Vincent; Demeter, Judit; di Raimondo, Francesco; Do, Young Rok; Domingo, Eva; Douvas, Michael; Dreyling, Martin; Ernst, Thomas; Fay, Keith; Ferrero, Silvia Fernandez; Flinn, Ian Winchester; Forero-Torres, Andres; Fox, Christopher; Friedberg, Jonathan; Fukuhara, Noriko; Garcia-Marco, Jose; Cruz, Jorge Gayoso; Codina, Jose Gomez; Gressin, Remy; Grigg, Andrew; Gurion, Ronit; Haioun, Corinne; Hajek, Roman; Hanel, Mathias; Hatake, Kiyohiko; Hensen, Robert; Horowitz, Netanel; Ishizawa, Kenichi; Islas-Ohlmayer, Miguel; Jacobsen, Eric; Janakiram, Murali; Jurczak, Wojciech; Kaminski, Mark; Kato, Koji; Kirgner, Ilya; Kuo, Ching-Yuan; Lazaroiu, Mihaela Cornelia; Du, Katell Le; Lee, Jong-Seok; LeGouill, Steven; LaRosee, Paul; Levi, Itai; Link, Brian; Maisonneuve, Herve; Maruyama, Dai; Mayer, Jiri; McCarty, John; McKay, Pam; Minami, Yosuke; Mocikova, Heidi; Morra, Enrica; Munoz, Javier; Nagai, Hirokazu; Opat, Stephen; Pettengell, Ruth; Pezzutto, Antonio; Pfreundschuh, Michael; Pluta, Andrzej; Porcu, PierLuigi; Quach, Hang; Rambaldi, Alessandro; Renwick, William; Reyes, Ruben; Izquierdo, Antonia Rodriguez; Ruan, Jia; Rusconi, Chiara; Salles, Gilles; Santoro, Armando; Sarriera, Jose; Shibayama, Hirohiko; Suh, Cheolwon; Sureda, Anna; Tanimoto, Mitsune; Taniwaki, Masafumi; Tilly, Herve; Trneny, Marek; Tsukamoto, Norifumi; Vitolo, Umberto; Walewski, Jan; Weidmann, Eckhart; Wilhelm, Martin; Witzens-Harig, Mathias; Yacoub, Abdulraheem; Yamamoto, Kazuhito; Yoon, Sung-Soo; Yun, Hwan Jung; Zain, Jasmine
    Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial
    In: Lancet , Jg. 393 2019, Nr. 10168, S. 229 – 240
    DOI (Open Access)
  • Kurtz, David M.; Esfahani, Mohammad S.; Scherer, Florian; Soo, Joanne; Jin, Michael C.; Liu, Chih Long; Newman, Aaron M.; Dührsen, Ulrich; Hüttmann, Andreas; Casasnovas, Olivier; Westin, Jason R.; Ritgen, Matthais; Böttcher, Sebastian; Langerak, Anton W.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Bahlo, Jasmin; Hallek, Michael; Tibshirani, Robert; Diehn, Maximilian; Alizadeh, Ash A.
    Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
    In: Cell , Jg. 178 2019, Nr. 3, S. 699 – 713.e19
    DOI (Open Access)
  • Sakarou, Maria; Eisele, Lewin; Dührsen, Ulrich; Hüttmann, Andreas
    Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement
    In: European Journal of Haematology , Jg. 102 2019, Nr. 3, S. 241 – 250
    DOI
  • Richter, Julia; Hüttmann, Andreas; Rekowski, Jan; Schmitz, Christine; Gärtner, Selina; Rosenwald, Andreas; Hansmann, Martin-Leo; Hartmann, Sylvia; Möller, Peter; Wacker, Hans-Heinrich; Feller, Alfred; Thorns, Christoph; Müller, Stefan; Dührsen, Ulrich; Klapper, Wolfram
    Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial : correlation with interim PET and outcome
    In: Blood Cancer Journal , Jg. 9 2019, Nr. 9, S. 67
    DOI (Open Access)
  • Kurtz, David M.; Scherer, Florian; Jin, Michael; Soo, Joanne; Craig, Alexander F.M.; Esfahani, Mohammad Shahrokh; Chabon, Jacob J.; Stehr, Henning; Liu, Chih Long; Tibshirani, Robert; Maeda, Lauren S.; Gupta, Neel K.; Khodadoust, Michael S.; Advani, Ranjana H.; Newman, Aaron M.; Dührsen, Ulrich; Hüttmann, Andreas; Meignan, Michel; Casasnovas, Olivier; Westin, Jason R.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Reply to J. Wang et al
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 9, S. 755 – 758
    DOI
  • Alashkar, Ferras; Vance, Colin; Herich-Terhürne, Dörte; Turki, Amin T.; Schmitz, Christine; Bommer, Martin; Hüttmann, Andreas; Dührsen, Ulrich; Vogel, Ulrich; Röth, Alexander
    Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibition
    In: Vaccine , Jg. 37 2019, Nr. 44, S. 6682 – 6687
    DOI
  • Hüttmann, Andreas; Rekowski, Jan; Müller, Stefan; Hertenstein, Bernd; Franzius, Christiane; Mesters, Rolf; Weckesser, Matthias; Kroschinsky, Frank; Kotzerke, Jörg; Ganser, Arnold; Bengel, Frank M.; La Rosée, Paul; Freesmeyer, Martin; Höffkes, Heinz-Gert; Hertel, Andreas; Behringer, Dirk; Prange-Krex, Gabriele; Griesshammer, Martin; Holzinger, Jens; Wilop, Stefan; Krohn, Thomas; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Schroers, Roland; Gaska, Tobias; Bernhard, Helga; Giagounidis, Aristoteles; Schütte, Jochen; Dienst, Ariane; Hautzel, Hubertus; Naumann, Ralph; Klein, Alfred; Hahn, Dennis; Pöpperl, Gabriele; Grube, Matthias; Marienhagen, Jörg; Schwarzer, Andreas; Kurch, Lars; Höhler, Thomas; Steiniger, Heike; Nückel, Holger; Südhoff, Thomas; Römer, Wolfgang; Brinkmann, Marcus; Ose, Claudia; Alashkar, Ferras; Schmitz, Christine; Dürig, Jan; Hoelzer, Dieter; Jöckel, Karl-Heinz; Klapper, Wolfram; Dührsen, Ulrich
    Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
    In: Annals of Hematology , Jg. 98 2019, Nr. 4, S. 897 – 907
    DOI
  • Borchmann, Sven; Müller, Horst; Haverkamp, Heinz; Baues, Christian; Marková, Jana; Hüttmann, Andreas; Glunz, Axel; Fuchs, Michael; Borchmann, Peter; Engert, Andreas
    Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma : an analysis of the German Hodgkin Study Group (GHSG)
    In: Leukemia , Jg. 33 2019, Nr. 2, S. 439 – 446
    DOI
  • Demirdas, Sedat; Hense, Jörg; Dührsen, Ulrich; Hüttmann, Andreas
    Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas
    In: Oncology Research and Treatment , Jg. 42 2019, Nr. 11
    DOI
  • Kurtz, David M.; Scherer, Florian; Jin, Michael C.; Soo, Joanne; Craig, Alexander F.M.; Esfahani, Mohammad Shahrokh; Chabon, Jacob J.; Stehr, Henning; Liu, Chih Long; Tibshirani, Robert; Maeda, Lauren S.; Gupta, Neel K.; Khodadoust, Michael S.; Advani, Ranjana H.; Levy, Ronald; Newman, Aaron M.; Dührsen, Ulrich; Hüttmann, Andreas; Meignan, Michel; Casasnovas, René-Olivier; Westin, Jason R.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Circulating tumor DNA measurements as early outcome predictors in diffuse large B-Cell lymphoma
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 28, S. 2845 – 2853
    DOI (Open Access)
  • Röth, Alexander; Bommer, Martin; Hüttmann, Andreas; Herich-Terhürne, Dörte; Kuklik, Nils; Rekowski, Jan; Lenz, Veronika; Schrezenmeier, Hubert; Dührsen, Ulrich
    Eculizumab in cold agglutinin disease (DECADE) : an open-label, prospective, bicentric, nonrandomized phase 2 trial.
    In: Blood Advances , Jg. 2 2018, Nr. 19, S. 2543 – 2549
    DOI (Open Access)
  • Pfeifer, Heike; Raum, Katharina; Markovic, Sandra; Nowak, Verena; Fey, Stephanie; Obländer, Julia; Pressler, Jovita; Böhm, Verena; Brüggemann, Monika; Wunderle, Lydia; Hüttmann, Andreas; Wäsch, Ralph; Beck, Joachim; Stelljes, Matthias; Viardot, Andreas; Lang, Fabian; Hoelzer, Dieter; Hofmann, Wolf-Karsten; Serve, Hubert; Weiss, Christel; Goekbuget, Nicola; Ottmann, Oliver G.; Nowak, Daniel
    Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
    In: Blood , Jg. 131 2018, Nr. 13, S. 1464 – 1475
    DOI (Open Access)
  • Zimmermann, Heiner; Babel, Nina; Dierickx, Daan; Morschhauser, Franck; Mollee, Peter; Zaucha, Jan M.; Dreyling, Martin H.; Dührsen, Ulrich; Reinke, Petra; Verhoef, Gregor; Subklewe, Marion; Hüttmann, Andreas; Tousseyn, Thomas; Bachy, Emmanuel; Hauser, Ingeborg A.; Tarella, Corrado; Van Den Neste, Eric; Gheysens, Olivier; Anagnostopoulos, Ioannis; Leblond, Veronique; Riess, Hanno; Choquet, Sylvain; Trappe, Ralf U.
    Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder : A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
    In: Transplantation , Jg. 102 2018, Nr. 11, S. 1914 – 1923
    DOI
  • Dührsen, Ulrich; Müller, Stefan; Hertenstein, Bernd; Thomssen, Henrike; Kotzerke, Jörg; Mesters, Rolf; Berdel, Wolfgang E.; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Kofahl-Krause, Dorothea; Bengel, Frank M.; Dürig, Jan; Matschke, Johannes; Schmitz, Christine; Pöppel, Thorsten; Ose, Claudia; Brinkmann, Marcus; La Rosée, Paul; Freesmeyer, Martin; Hertel, Andreas; Höffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Holzinger, Jens; Griesshammer, Martin; Giagounidis, Aristoteles; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Bernhard, Helga; Haberkorn, Uwe; Gaska, Tobias; Kurch, Lars; Van Assema, Daniëlle M.E.; Klapper, Wolfram; Hoelzer, Dieter; Geworski, Lilli; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas; Rekowski, Jan; Hüttmann, Andreas
    Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 20, S. 2024 – 2034
    DOI (Open Access)
  • Dührsen, Ulrich; Müller, Stefan; Rekowski, Jan; Hüttmann, Andreas
    Reply to H.J.A adams et al and C. Gisselbrecht
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 32, S. 3273 – 3274
    DOI
  • Wein, Frederik; Weniger, Marc; Höing, Benedikt; Arnolds, Judith; Hüttmann, Andreas; Hansmann, Martin-Leo; Hartmann, Sylvia; Küppers, Ralf
    Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma
    In: Cancer Immunology Research , Jg. 5 2017, Nr. 12, S. 1122 – 1132
    DOI
  • Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kühnhardt, Dagmar; Ostermann, Helmut; Schmitz, Norbert; Hertenstein, Bernd; Aulitzky, Walter; Maschmeyer, Georg; Vieler, Tom; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Kuhnert, Georg; Diehl, Volker; Dietlein, Markus; Engert, Andreas
    PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18) : final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
    In: Lancet , Jg. 390 2017, Nr. 10114, S. 2790 – 2802
    DOI
  • Cornely, Oliver A.; Leguay, Thibaut; Maertens, Johan; Vehreschild, Maria J.G.T.; Anagnostopoulos, Achilles; Castagnola, Carlo; Verga, Luisa; Rieger, Christina; Kondakci, Mustafa; Härter, Georg; Duarte, Rafael F.; Allione, Bernardino; Cordonnier, Catherine; Heussel, Claus Peter; Morrissey, C. Orla; Agrawal, Samir G.; Peter Donnelly, J.; Bresnik, Mark; Hawkins, Michael J.; Garner, Will; Gökbuget, Nicola; Jarchum, G.; Dictar, M.; Ramirez Borga, S.; Valledor, A.; Knoebl, P.; Greil, R.; Linkesch, W.; Sill, H.; De Prijck, B.; Sonet, A.; Theunissen, K.; Selleslag, D.; Vargas Schwarzbold, A.; Nucci, M.L.M.; Lopes de Castro Lobo, C.; Fogliatto, L.; Bonmati, C.; Turlure, P.; Herbrecht, R.; Thiebaut, A.; Michallet, M.; Egerer, G.; Silling, G.; Pfreundschuh, M.; Hasenkamp, J.; Kraemer, D.M.; Topp, M.; Heinz, W.; Junghanss, C.; Schaich, M.A.; Parmentier, S.; Roellig, C.; Beck, H.J.; Hüttmann, Andreas; Mousset, S.; Duenzinger, U.N.; Schwartz, S.; Ostermann, H.; Cornely, O.A.; Vehreschild, M.J.G.T.; Tsirigotis, P.; Matsouka, P.; Angelopoulou, M.K.; Karakantza, M.; Spyridonidis, A.; Kolomansky, A.; Moses, A.; Horowitz, N.; Rahav, G.; Aversa, F.; Velardi, A.; Pagano, L.; Gentile, G.; Gobbi, M.; Luppi, M.; Nosari, A.M.; Rambaldi, A.; Candoni, A.; Marbello, L.; Rossi, G.; Pogliani, E.; Moreira, I.; Nunes, A.; Botelho de Sousa, A.; Rubio Tejero, A.I.; Vallejo, C.; Vazquez, L.; Besalduch Vidal, J.; Gomez-Garcia de Soria, V.; Jurado Chacon, M.; González Campos, J.; Olavarria, E.; Barba, P.; de la Serna Torroba, J.; Heim, D.; Zimmerli, S.; Gerber, B.; Akova, M.; Bolaman, A.Z.; Tabak, F.; Akan, H.; Senol, E.
    Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
    In: Journal of Antimicrobial Chemotherapy , Jg. 72 2017, Nr. 8, S. 2359 – 2367
    DOI (Open Access)
  • Trappe, Ralf U.; Dierickx, Daan; Zimmermann, Heiner; Morschhauser, Franck; Mollee, Peter; Zaucha, Jan M.; Dreyling, Martin H.; Dührsen, Ulrich; Reinke, Petra; Verhoef, Gregor; Subklewe, Marion; Hüttmann, Andreas; Tousseyn, Thomas; Salles, Gilles; Kliem, Volker; Hauser, Ingeborg A.; Tarella, Corrado; Van Neste, Eric Den; Gheysens, Olivier; Anagnostopoulos, Ioannis; Leblond, Veronique; Riess, Hanno; Choquet, Sylvain
    Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trial
    In: Journal of Clinical Oncology (JCO) , Jg. 35 2017, Nr. 5, S. 536 – 543
    DOI (Open Access)
  • Borchmann, P.; Goergen, H.; Kobe, C.; Fuchs, M.; Greil, R.; Zijlstra, J. M.; Hüttmann, Andreas; Markova, J.; Meissner, J.; Feuring-Buske, M.; Bentz, M.; Dierlamm, J.; Kuhnhardt, D.; Lohri, A.; Novak, U.; Eichenauer, D.; Eich, H.; Baues, C.; Stein, H.; Diehl, V.; Kuhnert, G.; Dietlein, M.; Engert, A.
    Treatment reduction in patients with advanced-stage Hodgkin Lymphoma and negative interim PET : Final results of the international, randomized phase 3 trial HD 18 by the German Hodkin Study Group
    In: Haematologica / The Hematology Journal , Jg. 102 2017, Nr. Suppl. 2, S. 24 – 25
  • Röllig, Christoph; Serve, Hubert; Hüttmann, Andreas; Noppeney, Richard; Müller-Tidow, Carsten; Krug, Utz; Baldus, Claudia D.; Brandts, Christian H.; Kunzmann, Volker; Einsele, Hermann; Krämer, Alwin; Schäfer-Eckart, Kerstin; Neubauer, Andreas; Burchert, Andreas; Giagounidis, Aristoteles; Krause, Stefan W.; Mackensen, Andreas; Aulitzky, Walter; Herbst, Regina; Hänel, Mathias; Kiani, Alexander; Frickhofen, Norbert; Kullmer, Johannes; Kaiser, Ulrich; Link, Hartmut; Geer, Thomas; Reichle, Albert; Junghanß, Christian; Repp, Roland; Heits, Frank; Dürk, Heinz; Hase, Jana; Klut, Ina-Maria; Illmer, Thomas; Bornhäuser, Martin; Schaich, Markus; Parmentier, Stefani; Görner, Martin; Thiede, Christian; von Bonin, Malte; Schetelig, Johannes; Kramer, Michael; Berdel, Wolfgang E.; Ehninger, Gerhard
    Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML) : a multicentre, phase 2, randomised controlled trial
    In: The Lancet Oncology , Jg. 16 2015, Nr. 16, S. 1691 – 1699
    DOI
  • Hüttmann, Andreas; Müller, Stefan; Dührsen, Ulrich
    Outcome of aggressive non-Hodgkin lymphoma patients with a negative pretreatment positron emission tomography scan
    In: Leukemia and Lymphoma , Jg. 56 2015, Nr. 5, S. 1235 – 1235
  • Müller, Stefan; Hüttmann, Andreas; Rekowski, Jan; Geworski, Lilli; Pöppel, Thorsten; Bockisch, Andreas; Dührsen, Ulrich
    Positron Emission Tomography guided therapy of aggressive lympomas (PETAL) - the predictive value of quantitative PET
    In: Journal of Nuclear Medicine (JNM) , Jg. 56 2015, Nr. Suppl. 3, S. 210
  • Roellig, C.; Kramer, M.; Mueller-Tidow, C.; Hüttmann, Andreas; Noppeney, Richard; Kunzmann, V.; Baldus, C. D.; Brandts, C.; Kraemer, A.; Schaefer-Eckart, K.; Neubauer, A.; Krause, S. W.; Giagounidis, A.; Aulitzky, W.; Bornhaeuser, M.; Schaich, M.; Parmentier, S.; Thiede, C.; von Bonin, M.; Schetelig, J.; Serve, H.; Berdel, W. E.; Ehninger, G.
    Updated results from the soraml trial comparing sorafenib versus placebo in addition to standard therapy in younger patients with newly diagnosted acute myeloid leukemia
    In: Haematologica / The Hematology Journal , Jg. 100 2015, Nr. Suppl. 1, S. 318 – 318
    (Open Access)
  • Hoelzer, Dieter; Walewski, Jan; Döhner, Hartmut; Viardot, Andreas; Hiddemann, Wolfgang; Spiekermann, Karsten; Serve, Hubert; Dührsen, Ulrich; Hüttmann, Andreas; Thiel, Eckhard; Dengler, Jolanta; Kneba, Michael; Schaich, Markus; Schmidt-Wolf, Ingo G H; Beck, Joachim; Hertenstein, Bernd; Reichle, Albrecht; Domanska-Czyz, Katarzyna; Fietkau, Rainer; Horst, Heinz-August; Rieder, Harald; Schwartz, Stefan; Burmeister, Thomas; Gökbuget, Nicola
    Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy : report of a large prospective multicenter trial
    In: Blood , Jg. 124 2014, Nr. 26, S. 3870 – 3879
    DOI
  • Dührsen, Ulrich; Hüttmann, Andreas; Mueller, Stefan; Hertenstein, Bernd; Kotzerke, Joerg; Mesters, Rolf; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Franzke, Anke; Bengel, Frank; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Rekowski, Jan; Ose, Claudia; Brinkmann, Marcus; LaRosee, Paul; Freesmeyer, Martin; Hertel, Andreas; Hoeffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Fricke, Eva; Griesshammer, Martin; Giagounidis, Aristotele; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Brecht, Arne; Haberkorn, Uwe; Gaska, Tobias; Klapper, Wolfram; Hoelzer, Dieter; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas
    Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)
    In: Blood , Jg. 124 2014, Nr. 21, S. 391
    DOI
  • Göbel, Maria; Eisele, Lewin; Möllmann, Michael; Hüttmann, Andreas; Johansson, Patricia; Scholtysik, Rene; Bergmann, Manuela; Busch, Raymonde; Döhner, Hartmut; Hallek, Michael; Seiler, Till; Stilgenbauer, Stephan; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
    In: PLoS ONE , Jg. 23 2013, Nr. 8, S. e72107
    DOI (Open Access)
  • Hanoun, Maher; Eisele, Lewin; Suzuki, Masako; Greally, John M.; Hüttmann, Andreas; Aydin, Semra; Scholtysik, René; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia
    In: PLoS ONE , Jg. 7 2012, Nr. 12, S. e34347
    DOI (Open Access)
  • Gökbuget, Nicola; Stanze, Daniel; Beck, Joachim D.; Diedrich, Helmut; Horst, Heinz A.; Hüttmann, Andreas; Kobbe, Guido; Kreuzer, Karl A.; Leimer, Lothar; Reichle, Albrecht; Schaich, Markus A.; Schwartz, Stefan; Serve, Hubert L.; Starck, Michael; Stelljes, Matthias; Stuhlmann, Reingard; Viardot, Andreas; Wendelin, Knut; Freund, Matthias R.F.; Hoelzer, Dieter F.; German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
    Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
    In: Blood , Jg. 120 2012, Nr. 10, S. 2032 – 2041
    DOI
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, K.; Jöckel, Karl-Heinz; Moebus, Susanne; on behalf of the Heinz Nixdorf Recall Study Investigative Group
    Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany
    In: Annals of Hematology , Jg. 91 2012, Nr. 2, S. 243 – 248
    DOI
  • Gobel, M.; Eisele, Lewin; Hüttmann, Andreas; Bergmann, M.; Busch, R.; Stilgenbauer, S.; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin plasma concentration is a novel independent prognostic marker in chronic lymphocytic leukemia
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 100
  • Sakarou, M.; Dührsen, Ulrich; Hüttmann, Andreas
    The GMALL-B-ALL/NHL protocol is an effective salvage treatment in relapsed and refractory aggressive B-cell non-Hodgkins lymphomas
    In: Onkologie , Jg. 35 2012, Nr. 6, S. 40
  • Gökbuget, Nicola; Basara, Nadezda; Baurmann, Herrad; Beck, Joachim; Brüggemann, Monika; Diedrich, Helmut; Güldenzoph, Björn; Hartung, Gernot; Horst, Heinz-August; Hüttmann, Andreas; Kobbe, Guido; Naumann, Ralph; Ratei, Richard; Reichle, Albrecht; Serve, Hubert; Stelljes, Matthias; Viardot, Andreas; Wattad, Mohammed; Hoelzer, Dieter
    High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation
    In: Blood , Jg. 118 2011, Nr. 13, S. 3504 – 3511
    DOI
  • Röth, Alexander; Hüttmann, Andreas; Dührsen, U.; Philipp, Thomas
    Inhibition of the Terminal Complement System Using Eculizumab for the Treatment of Cold Agglutinin Disease (CAD)
    184. Tagung der Rheinisch-Westfälischen Gesellschaft für Innere Medizin e.V.,
    In: Medizinische Klinik , Jg. 105 2010, Nr. 3, S. 213 – 214
    DOI
  • Hüttmann, Andreas; Müller, Stefan; Jöckel, Karl-Heinz; Dührsen, Ulrich
    Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphoma
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. 27, S. e488 – e489
    DOI
  • Christoph, Sandra; Hüttmann, Andreas; Dührsen, Ulrich; Röth, Alexander
    Porphyria cutanea tarda
    In: British Journal of Haematology , Jg. 148 2010, Nr. 4, S. 493
    DOI
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, U.; Führer, A.; Kieruzel, S.; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of monoclonal gammopathy of undetermindes significance in a densley populated, highly industrialized area in Germany
    15th Congress of the European Hematology Association, Spain, Barcelona, June 10–13, 2010,
    In: Haematologica, the hematology journal , Jg. 95 2010, Nr. Suppl. 2 , S. 394, 0949
  • Eisele, Lewin; Durig, J.; Hüttmann, Andreas; Dührsen, U.; Führer, A.; Kieruzel, S.; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of monoclonal gammopathy of undetermined significance in a densely populated, highly industrialized area in Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6 , S. 95, V321
    DOI
  • Dührsen, Ulrich; Hüttmann, Andreas; Dürig, Jan
    Prognostic Significance of Molecular Remission in Follicular Lymphoma
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. 30, S. e613
    DOI
  • Hüttmann, Andreas; Klein-Hitpaß, Ludger; Thomale, Jürgen; Deenen, R.; Nückel, Holger; Ebeling, Peter; Führer, A.; Edelmann, J.; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status
    In: Leukemia , Jg. 20 2006, Nr. 10, S. 1774 – 1782
    DOI
  • Nückel, Holger; Hüttmann, Andreas; Klein-Hitpaß, Ludger; Schroers, Roland; Führer, Anja; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia
    In: Leukemia & Lymphoma , Jg. 47 2006, Nr. 6, S. 1053 – 1061
    DOI
  • Dürig, Jan; Nückel, Holger; Hüttmann, Andreas; Kruse, Elisabeth; Hölter, Tanja; Halfmeyer, Katja; Führer, Anja; Rudolph, Roland; Kalhori, Nasa; Nusch, Arnd; Deaglio, Silvia; Malavasi, Fabio; Möröy, Tarik; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia
    In: Blood , Jg. 101 2003, Nr. 7, S. 2748 – 2755
    DOI
  • Dürig, Jan; Naschar, M.; Schmücker, U.; Renzing-Köhler, K.; Hölter, T.; Hüttmann, Andreas; Dührsen, Ulrich
    CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
    In: Leukemia , Jg. 16 2002, Nr. 1, S. 30 – 35
    DOI

    • Abstracts

  • Ferdinandus, Justin; Kaul, Helen; Fosså, Alexander; Hüttmann, Andreas; Keil, Felix; Ko, Yon-Dschun; Hitz, Felicitas; Schwarz, Michaela; Trenker, Corinna; Kerkhoff, Andrea; Staib, Peter; Wille, Kai; Dresel, Irmgard; Hahn, Dennis; Hertenstein, Bernd; Moosmann, Peter; Mey, Ulrich; Balabanov, Stefan; Armytage, Tasman; Roncolato, Fernando; Hellmuth, Johannes Christian; Kreissl, Stefanie; Fuchs, Michael; Schneider, Gundolf; Tharmaseelan, Hishan; Eichenauer, Dennis A; von Tresckow, Bastian; Borchmann, Peter; Bröckelmann, Paul J.
    PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma : Results of the Phase 2 Part of the GHSG HD21 Trial
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood , Jg. 144 2024, Nr. Supplement 1, S. 568 – 568
    DOI (Open Access)
  • Denker, Sophy; Bittner, Aitomi; Kase, Julia; Frick, Mareike; Hoffmann, Jörg; Trenker, Corinna; Keller, Ulrich; Bogner, Christian; Hüttmann, Andreas; Dürig, Jan; Janz, Martin; Mathas, Stephan; Marks, Reinhard; Krohn, Ulrike; Na, Il-Kang; Richter-Pechanska, Paulina; Bhattacharya, Animesh; Gebauer, Bernhard; Savic, Lynn; Hübner, Norbert; Akalin, Altuna; Eils, Roland; Bullinger, Lars; Schmitt, Clemens
    Targeted Treatment Additions Ibrutinib + Bortezomib + R-CHOP for Higher-Risk DLBCL : Efficacy, Feasibility and Molecular Signatures for Future Treatment Decisions
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood , Jg. 144 2024, Nr. Supplement 1, S. 6188
    DOI (Open Access)
  • Borchmann, Peter; Moccia, Alden A; Greil, Richard; Schneider, Gundolf; Hertzberg, Mark; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Dierlamm, Judith; Haenel, Mathias; Meissner, Julia; Mathas, Stephan; Zijlstra, Josee M; Fosså, Alexander; Ferdinandus, Justin; Fuchs, Michael; Klapper, Wolfram; Eich, Hans-Theodor; Kobe, Carsten; Diehl, Volker
    Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma : GHSG HD21, a randomized study
    2024 ASCO Annual Meeting, May 31 - June 4, 2024, Chicago, Ill., USA and online,
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. 17, Supplement, LBA7000
    DOI
  • Zwezerijnen, G.; Bes, A.L.; Heymans, M.W.; Dührsen, Ulrich; Hüttmann, Andreas; Hanoun, C.
    Combining Baseline and End of Treatment Quantitative PET Parameters to Improve Progression-Free Survival Prediction in DLBCL
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 50 2023, Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. S47 – S48
    DOI
  • Borchmann, Peter; Moccia, Alden; Greil, Richard; Schneider, Gundolf; Hertzberg, Mark S.; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Schaub, Valdete; Hänel, Mathias; Novak, Urban; Meissner, Julia; Zimmermann, Andreas; Mathas, Stephan; Zijlstra, Josée M; Fosså, Alexander; Viardot, Andreas; Hertenstein, Bernd; Martin, Sonja; Giri, Pratyush; Kamper, Peter; Molin, Daniel L.; Kreissl, Stefanie; Ferdinandus, Justin; Fuchs, Michael; Rosenwald, Andreas; Klapper, Wolfram; Eich, Hans; Baues, Christian; Hallek, Michael; Dietlein, Markus; Kobe, Carsten; Diehl, Volker
    Comprehensive Analysis of Treatment Related Morbidity and Progression-Free Survival in the GHSG Phase III HD21 Trial
    In: Blood , Jg. 142 2023, Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 3057 – 3057
    DOI (Open Access)
  • Denker, S.; Bittner, A.; Frick, M.; Hüttmann, Andreas; Dührig, J.; Schmitt, C. A.; et al.
    Ibrutinib + bortezomib + R-CHOP for higher-risk DLBCL : Efficacy, feasibility and molecular predictors
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 24
    DOI (Open Access)
  • Denker, S.; Bittner, A.; Frick, M.; Kase, J.; Hoffmann, J.; Trenker, C.; Keller, U.; Bogner, C.; Hüttmann, Andreas; Dürig, Jan; Janz, M.; Mathas, S.; Marks, R.; Krohn, U.; Na, I.; Bhattacharya, A.; Hübner, N.; Akalin, A.; Bullinger, L.; Schmitt, C.A.
    Ibrutinib + bortezomib + R‐CHOP for higher‐risk DLBCL : Feasibility, efficacy and molecular predictors
    In: Hematological Oncology , Jg. 41 2023, Nr. S2, 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, S. 424 – 425
    DOI (Open Access)
  • Hoffmann, Christian; Ringbaek, Toke; Garcia, Alina Santiago; Flühs, Andrea; Heintz, Martin; Lübcke, Wolfgang; Indenkämpen, Frank; Sauerwein, Wolfgang; Moliavi, Sourour; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Eckstein, Anja; Johansson, Patricia; Hüttmann, Andreas; Stuschke, Martin; Guberina, Maja
    Linsenschonende Elektronenbestrahlung bei konjunktivalen Non-Hodgkin Lymphomen : Monozentrische Langzeitdaten zur Efektivität und Nebenwirkungen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S106
    DOI (Open Access)
  • Zucca, Emanuele; Ceriani, Luca; Davies, Andrew S.; Ciccone, Giovannino; Ricardi, Umberto; Di Rocco, Alice; Kryachok, Iryna; Botto, Barbara; Balzarotti, Monica; Tucci, Alessandra; Zilioli, Vittorio Ruggero; Usai, Sara; Arcaini, Luca; Pennese, Elsa; Dabrowska-Iwanicka, Anna; Ferreri, Andrés José María; Merli, Franceso; Zhao, Wei Li; Hodgson, David; Ionescu, Codruta; Rigacci, Luigi; Cellini, Claudia; Stelitano, Caterina; Volpetti, Stefano; Minoia, Carla; Spina, Michele; Fossa, Alexander; Mikhaeel, George; Cwynarski, Kate; Janikova, Andrea; Stepanishyna, Yana; Jerkeman, Mats; Hüttmann, Andreas; da Silva, Maria Gomes; Stevens, Don A.; Barrington, Sally F; Małkowski, Bogdan; Metser, Ur; Versari, Annibale; Chauvie, Stephane; Bagni, Oreste; Cozens, Kelly; Perticone, Sonia; Ielmini, Nicoletta; Deantonio, Letizia; Walewski, Jan; Trneny, Marek; Gospodarowicz, Mary; Cavalli, Franco; Johnson, Peter; Martelli, Maurizio
    Survival Patterns of Non-Randomized Patients in the IELSG37 Study : Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma
    65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,
    In: Blood , Jg. 142 2023, Nr. Supplement 1, S. 1718 – 1721
    DOI (Open Access)
  • Ferdinandus, J.; Moccia, A.; Greil, R.; Hüttmann, Andreas; Borchmann, P.; et al.; German Hodgkin Study Group (GHSG)
    Treatment related organ toxicities at one year follow-up in patients with advanced stage classical Hodgkin Lymphoma : results from the randomized phase III HD21 trial by the German Hodgkin Study Group
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 111
    DOI (Open Access)
  • Boegeholz, Jan; Alig, Stefan K.; Sworder, Brian; Schroers-Martin, Joseph; Macaulay, Charles; Craig, Alexander F.M.; Duehrsen, Ulrich; Hüttmann, Andreas; Westin, Jason; Cherng, Hua-Jay J.; Miklos, David B.; Frank, Matthew J; Diehn, Maximilian; Kurtz, David M.; Alizadeh, Ash A.
    Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy
    In: Blood , Jg. 140 2022, Nr. Supplement 1: 64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans, S. 8609 – 8610
    DOI (Open Access)
  • Sworder, Brian; Kurtz, David M.; Alig, Stefan K.; Frank, Matthew J; Shukla, Navika D.; Garofalo, Andrea; Macaulay, Charles; Shahrokh Esfahani, Mohammad; Olsen, Mari; Hamilton, James; Hosoya, Hitomi; Hamilton, Mark P; Spiegel, Jay Y.; Baird, John H.; Carleton, Mia; Craig, Alexander F.M.; Younes, Sheren F.; Sahaf, Bita; Sheybani, Natasha; Schroers-Martin, Joseph; Liu, Chih Long; Oak, Jean S; Jin, Michael C.; Beygi, Sara; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; Westin, Jason; Khodadoust, Michael S.; Natkunam, Yasodha; Majzner, Robbie G.; Mackall, Crystal L.; Diehn, Maximilian; Miklos, David B.; Alizadeh, Ash A.
    Determinants of Resistance to Engineered T-Cell Therapies Targeting CD19 in Large B-Cell Lymphomas
    64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,
    In: Blood , Jg. 140 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 1301 – 1303
    DOI (Open Access)
  • Eertink, Jakoba J.; Zwezerijnen, Gerben JC; Heymans, Martijn W.; Pieplenbosch, Simone; Wiegers, Sanne E.; Dührsen, Ulrich; Hüttmann, Andreas; Kurch, Lars; Hanoun, Christine; Lugtenburg, Pieternella; Barrington, Sally F.; Mikhaeel, George; Ceriani, Luca; Zucca, Emanuele; Czibor, Sandor; Györke, Tamás; Chamuleau, Martine E.D.; Hoekstra, Otto S.; de Vet, Henrica C.W; Boellaard, Ronald; Zijlstra, Josée M.
    External Validation Shows That Baseline PET Radiomics Outperform the IPI Risk Score for Prediction of Outcome in DLBCL
    64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH): DEC 10-13, 2022; New Orleans, USA,
    In: Blood , Jg. 140 2022, Nr. Supplement 1, S. 777 – 778
    DOI (Open Access)
  • Hüttmann, Andreas
    PET/CT bei indolenten Lymphoma : wann und warum?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment , Jg. 45 2022, Nr. Supplement 2, S. 147
    DOI (Open Access)
  • Van Dijk, Erik; Janssen, Jurriaan; Mendeville, Matias; Los-De Vries, G. Tjitske; Roemer, Margaretha GM; Stathi, Phylicia; Richter, Julia; Kim, Yong Soo; Klapper, Wolfram; Dührsen, Ulrich; Hüttmann, Andreas; Lugtenburg, P. J; Zijlstra, Josée M.; Kersten, Marie Jose; de Jong, Daphne; Chamuleau, Martine E.D.; Ylstra, Bauke
    The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma
    64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,
    In: Blood , Jg. 140 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 9261 – 9263
    DOI (Open Access)
  • Borchmann, Peter; Moccia, Alden; Greil, Richard; Hertzberg, Mark; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Dierlamm, Judith; Haenel, Mathias; Novak, Urban; Meissner, Julia; Zimmermann, Andreas; Mathas, Stephan; Zijlstra, Josée M.; Fosså, Alexander; Viardot, Andreas; Hertenstein, Bernd; Martin, Sonja; Giri, Pratyush; Kamper, Peter; Molin, Daniel; Kreissl, Stefanie; Fuchs, Michael; Schneider, Gundolf; Rosenwald, Andreas; Klapper, Wolfram; Eich, Hans; Baues, Christian; Hallek, Michael; Dietlein, Markus; Kobe, Carsten; Diehl, Volker; Engert, Andreas
    Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma : Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group
    64th Annual Meeting and Exposition of the American Society of Hematology, December 10 - 13, 2022, New Orleans,
    In: Blood , Jg. 140 2022, Nr. Supplement 1: 64th Annual Meeting, S. 771 – 773
    DOI (Open Access)
  • Eertink, Jakoba J; Zwezerijnen, Gerben J.C; Wiegers, Sanne E; Chamuleau, Martine E.D; Lugtenburg, Pieternella; De Jong, Daphne; Ylstra, Bauke; Mendeville, Matias; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Richter, Julia; Klapper, Wolfram; Hoekstra, Otto S; de Vet, Henrica C.W; Boellaard, Ronald; Zijlstra, Josée M
    Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood , Jg. 138 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 451 – 453
    DOI (Open Access)
  • Zinzani, P. L.; Illidge, T.; Horwitz, S. M.; Hüttmann, Andreas; Trümper, L.; et al.
    Echelon-2 (NCT01777152), a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin plus CHP VS CHOP in Previously Untreated Patients with CD30-Positive Peripheral T-Cell Lymphoma : 5-Year Results
    48th Congress of the Italian Society of Hematology, 24-27 October 2021, Milan, Italy,
    In: Haematologica / The Hematology Journal , Jg. 106 2021, Nr. 10, S3: 48th Congress of the Italian Society of Hematology, 24-27 October 2021, S. 3
    DOI (Open Access)
  • Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Wilhelm, Martin; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M.; Krüger, William Hermann; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ulrich, Kathleen; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.
    Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma : A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood , Jg. 138 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 4533 – 4535
    DOI (Open Access)
  • Kurtz, David Matthew; Chabon, Jacob J.; Soo, Joanne; Co Ting Keh, Lyron; Alig, Stefan; Schultz, Andre; Jin, Michael C.; Scherer, Florian; Craig, Alexander F.M.; Liu, Chih Long; Duehrsen, Ulrich; Hüttmann, Andreas; Casasnovas, René-Olivier; Westin, Jason; Roschewski, Mark J.; Wilson, Wyndham Hopkins; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Phased variants improve DLBCL minimal residual disease detection at the end of therapy
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 7565 – 7565
    DOI (Open Access)
  • Fischer, Luca; Jiang, Linmiao; Bittenbring, Joerg; Hübel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Jürgen; Glass, Bertram; Hüttmann, Andreas; Schaefer-Eckart, Kerstin; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin H.; Hoster, Eva
    The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma : A Long Term Pooled Trials Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood , Jg. 138 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3551 – 3553
    DOI (Open Access)
  • Iyer, Swaminathan; Trümper, Lorenz; O’Connor, Owen A.; Pro, Barbara; Illidge, Tim; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Menne, Tobias; Belada, David; Illès, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hüttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Zinzani, Pier Luigi; Miao, Harry; Bunn, Veronica; Fenton, Keenan; Fanale, Michelle; Puhlmann, Markus; Horwitz, Steven
    The ECHELON-2 Trial : 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
    Society of Hematologic Oncology 9th Annual Meeting ; September 8–11, 2021, Houston, Texas, USA & Virtual Venue,
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 21 2021, Nr. Suppl. 1, S. S411
    DOI
  • Momotow, J.; Sasse, S.; Plütschow, A.; Hüttmann, Andreas; Basara, N.; Könecke, C.; Martin, S.; Bentz, M.; Große-Thie, C.; Thorspecken, S.; Wit, M. de; Kobe, C.; Dietlein, M.; von Tresckow, Bastian; Fuchs, M.; Borchmann, P.; Engert, A.
    AFM13 in patients with relapsed or refractory Hodgkin Lymphoma : Final results of an open-label, randomized, multicenter phase II trial
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment , Jg. 43 2020, Nr. Suppl. 4, S. 89
    DOI (Open Access)
  • Mikhaeel, N.; Heymans, M. W.; de Vet, H. C. W.; Eertink, J. J.; Boellaard, R.; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Ceriani, L.; Zucca, E.; Hoekstra, O. S.; Zijlstra, J. M.; Barrington, S.
    Characteristics of the relationship between MTV and survival in diffuse large B-cell lymphoma : A PETRA consortium study
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 47 2020, Nr. Supplement 1, S. S357
    DOI (Open Access)
  • Hüttmann, Andreas
    Classical Hodgkin-Lymphoma : PET-guided therapy and implementation of new substances from a global perspective
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment , Jg. 43 2020, Nr. Suppl. 4, S. 4
    DOI (Open Access)
  • Kaddu-Mulindwa, D.; Altmann, B.; Held, G.; Angel, S.; Stilgenbauer, S.; Thurner, L.; Bewarder, Moritz; Schwier, M.; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Pöschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment , Jg. 43 2020, Nr. Suppl. 4, S. 55 – 56
    DOI (Open Access)
  • Alashkar, Ferras; Carpinteiro, Alexander; Bauer, Sebastian; Hüttmann, Andreas; Dührsen, Ulrich; Reinhardt, Hans Christian; Röth, Alexander
    Think twice : Anemia of chronic disease (ACD) due to angiomatoid fibrous histiocytoma (AFH)
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment , Jg. 43 2020, Nr. Suppl. 4, S. 181
    DOI (Open Access)
  • Wermann, W. K.; Schwartz, S.; Fiedler, W.; Kayser, S.; Hüttmann, Andreas; Alakel, N.; Bargou, R.; Faul, C.; Heidenreich, D.; Jung, W.; Martin, S.; Subklewe, M.; Topp, M.; Viardot, A.; Vucinic, V.; Wäsch, R.; Brüggemann, M.; Gökbuget, N.
    Interim results of a multicenter, single-arm study to assess Blinatumomab in adult patients (pts) with minimal residual disease (MRD) of B-precursor (BCP) acute lymphoblastic leukemia (GMALL-MOLACT1-BLINA)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 42 2019, Nr. Supplement 4: Abstracts, S. 174 – 175
    DOI (Open Access)
  • Bröckelmann, Paul J; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas
    Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,
    In: Blood , Jg. 134 2019, Nr. Supplement_1: 61st ASH Annual Meeting, S. 236 – 236
    DOI (Open Access)
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Ziepert, Marita; Menhart, Karin; Grosse, Jirka; Angel, Stephanie; Stilgenbauer, Stephan; Pfreundschuh, Michael; Herrmann, Ken; Duehrsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Hellwig, Dirk; Poeschel, Viola
    Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
    Konferenz 61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,
    In: Blood , Jg. 134 2019, Nr. Supplement_1, S. 2892 – 2892
    DOI (Open Access)
  • Alig, Stefan; Macaulay, Charles; Kurtz, David M.; Dührsen, Ulrich; Hüttmann, Andreas; Jin, Michael C.; Sworder, Brian; Garofalo, Andrea; Esfahani, Mohammad Shahrokh; Soo, Joanne; Scherer, Florian; Craig, Alexander; Casasnovas, Olivier; Westin, Jason R.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma
    61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,
    In: Blood , Jg. 134 2019, Nr. Supplement_1, S. 491 – 491
    DOI (Open Access)
  • Trümper, L.; O’Connor, O. A.; Pro, B.; Illidge, T. M.; Advani, R. H.; Bartlett, N. L.; Haaber Christensen, J.; Morschhauser, F.; Domingo- Domenech, E.; Rossi, G.; Kim, W. S.; Feldman, T. A.; Lennard, A.; Belada, D.; Illés, Á.; Tobinai, K.; Tsukasaki, K.; Yeh, S.-P.; Shustov, A. R.; Hüttmann, Andreas; Savage, K. J.; Yuen, S.; Iyer, S.; Zinzani, P. L.; Hua, Z.; Little, M.; Rao, S.; Woolery, J.; Manley, T.; Horwitz, S. M.
    The ECHELON-2 trial : Results of a randomised, double-blind, active-controlled phase 3 study of brentuximab vedotin and CHP (A+CHP) vs CHOP in the frontline treatment of patients (pts) with CD30⁺ peripheral T-cell lymphomas (PTCLs)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 42 2019, Nr. Supplement 4: Abstracts, S. 23
    DOI (Open Access)
  • Eertink, Jakoba J; Burggraaff, Coreline N; Heymans, Martijn W; Barrington, Sally F; Mikhaeel, George; Dührsen, Ulrich; Hüttmann, Andreas; Ceriani, Luca; Zucca, Emanuele; Carr, Robert; Györke, Tamás; Fanti, Stefano; Higley, Howard R; Knopp, Michael V; Schöder, Heiko; Loft, Annika; Hutchings, Martin; Kostakoglu, Lale; Lugtenburg, Pieternella; Wiegers, Sanne E; Pieplenbosch, Simone; Boellaard, Ronald; Hoekstra, Otto S; Zijlstra, Josée M; de Vet, Henrica C.W.
    The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma : An Individual Patient Data Meta-Analysis By the Petra Consortium
    61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,
    In: Blood , Jg. 134 2019, Nr. Supplement_1, S. 487
    DOI (Open Access)
  • von Tresckow, Bastian; Hüttmann, Andreas; Vucinic, Vladan; Mueller, Horst; Plütschow, Annette; Viardot, Andreas; Topp, Max S.; Kobe, Carsten; Böll, Boris; Eichenauer, Dennis A.; Sasse, Stephanie; Haverkamp, Heinz; Fuchs, Michael; Engert, Andreas; Borchmann, Peter
    Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma : A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1, S. 2912 – 2912
    DOI (Open Access)
  • Rekowski, Jan; Hüttmann, Andreas; Schmitz, Christine; Müller, Stefan; Jöckel, Karl-Heinz; Duehrsen, Ulrich
    Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial : Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1, S. 1696 – 1696
    DOI (Open Access)
  • Schroers-Martin, Joseph G; Garofalo, Andrea; Soo, Joanne; Jin, Michael C.; Kurtz, David M.; Buedts, Lieselot; Dührsen, Ulrich; Hüttmann, Andreas; Cottereau, Anne Ségolène; Meignan, Michel; Casasnovas, Olivier; Westin, Jason R.; Gaidano, Gianluca; Rossi, Davide; Roschewski, Mark; Wilson, Wyndham H.; Advani, Ranjana H; Vandenberghe, Peter; Diehn, Maximilian; Khush, Kiran; Alizadeh, Ash A.
    Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing
    Konferenz 60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1, S. 2861 – 2861
    DOI (Open Access)
  • Richter, Julia; Hüttmann, Andreas; Rekowski, Jan; Schmitz, Christine; Gärtner, Selina; Ose, Claudia; Rosenwald, Andreas; Hansmann, Martin-Leo; Hartmann, Sylvia; Moeller, Peter; Wacker, Hans-Heinrich; Feller, Alfred; Thorns, Christoph; Müller, Stefan; Duehrsen, Ulrich; Klapper, Wolfram
    Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial
    In: Blood , Jg. 132 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4188 – 4188
    DOI (Open Access)
  • Jin, Michael C.; Schroers-Martin, Joseph G; Kurtz, David M.; Buedts, Lieselot; Esfahani, Mohammad S; Macaulay, Charles; Sworder, Brian; Soo, Joanne; Glover, Cynthia; Roschewski, Mark; Wilson, Wyndham H.; Dührsen, Ulrich; Hüttmann, Andreas; Rossi, Davide; Gaidano, Gianluca; Westin, Jason R.; Maeda, Lauren S.; Advani, Ranjana H; Vandenberghe, Peter; Diehn, Maximilian; Alizadeh, Arash A.
    Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1, S. 2838 – 2838
    DOI (Open Access)
  • Hess, Georg; Hüttmann, Andreas; Meissner, Julia; Marks, Reinhard; Dreyling, Martin; Keller, Ulrich; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Deuster, Oliver; van Oordt, Christina; Theobald, Matthias; Lenz, Georg
    Obinutuzumab (GA101) in Combination with Pixantrone for the Treatment of Patients with Relapsed Aggressive B-Cell Lymphoma : Â a Phase II Trial (GOAL)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1, S. 1678 – 1678
    DOI (Open Access)
  • Koeppen, Susanne; Alashkar, Ferras; Stolte, B.; Hüttmann, Andreas
    Predominantly motor polyneuropathy following brentuximab vedotin
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 319
    DOI (Open Access)
  • Horwitz, Steven M.; O'Connor, Owen A.; Pro, Barbara; Illidge, Tim M.; Fanale, Michelle A.; Advani, Ranjana H; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana A.; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei R.; Hüttmann, Andreas; Savage, Kerry J; Yuen, Sam; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Trümper, Lorenz
    The ECHELON-2 Trial : Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 997 – 997
    DOI (Open Access)
  • Röllig, C.; Serve, H.; Hüttmann, Andreas; Noppeney, Richard; Müller-Tidow, Carsten; Krug, U.; Baldus, C. D.; Brandts, C. H.; Kunzmann, V.; Einsele, H.; Krämer, A.; Schäfer-Eckart, K.; Neubauer, A.; Burchert, A.; Giagounidis, A.; Krause, S. W.; Mackensen, A.; Aulitzky, W.; Herbst, R.; Hänel, M.; Kiani, A.; Frickhofen, N.; Kullmer, J.; Kaiser, U.; Link, H.; Geer, T.; Reichle, A.; Junghanß, C.; Bornhäuser, M.; Schaich, M.; Thiede, C.; Schetelig, J.; Kramer, M.; Berdel, W. E.; Ehninger, G.; Studienallianz Leukämie (SAL)
    The addition of sorafenib to standard AML treatment results in a substantial reduction in relapse risk and improved survival : Updated results from long-term follow-up of the randomized-controlled SORAML trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 9
    DOI (Open Access)
  • Dührsen, Ulrich; Hüttmann, Andreas; Muller, S.; Hertenstein, B.; Thomssen, H.; Kotzerke, J.; Mesters, R.; Berdel, W. E.; Franzius, C.; Kroschinsky, F.; Weckesser, M.; Kofahl-Krause, D.; Bengel, F. M.; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Ose, C.; Brinkmann, M.; La Rosee, P.; Freesmeyer, M.; Hertel, A.; Hoffkes, H. G.; Behringer, D.; Prange-Krex, G.; Wilop, S.; Krohn, T.; Holzinger, J.; Griesshammer, M.; Giagounidis, A.; Raghavachar, A.; Maschmeyer, G.; Brink, I.; Bernhard, H.; Haberkorn, U.; Gaska, T.; Kurch, L.; Klapper, W.; Hoelzer, D.; Geworski, L.; Jöckel, Karl-Heinz; Scherag, Andre; Rekowski, J.; Bockisch, Andreas; PETAL Trial Investigators
    Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas -final results of the PETAL trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 29. September-3. Oktober 2017, Stuttgart, Germany,
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. Suppl. 3, S. 202 – 203
    DOI
  • Röth, Alexander; Hüttmann, Andreas; Dührsen, Ulrich
    DECADE Trial : Inhibition of theterminal complement system using the anti-C5 antibody eculizumab for the treatment of cold agglutinin disease (CAD)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 112
    DOI
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Führer, Anja; Kieruzel, Sabrina; Assert, Roland; Bokhof, Beate; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany
    In: Blood , Jg. 116 2010, Nr. 21, 4037
    DOI

    • Poster / Posterbeiträge

  • Topp, M.; Hüttmann, Andreas; Kimmich, C.; Hänel, M.; Strickland, D.; Weber, T.
    Global Phase 2 Basket Trial of Nanatinostat in Combination with Valganciclovir in Patients with EBV-Positive (EBV plus ) Relapsed/Refractory Lymphomas (NAVAL-1, trial in progress)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 186 – 187
    DOI (Open Access)
  • Hanoun, Christine; Heymans, Martijn; Wiegers, Sanne; Bes, Annelies; Duehrsen, Ulrich; Hüttmann, Andreas; Kurch, Lars; Barrington, Sally F; Mikhaeel, George; Lugtenburg, Pieternella; Ceriani, Luca; Zucca, Emanuele; Gyorke, Tamas; Czibor, Sandor; Zwezerijnen, Gerben; Boellaard, Ronald; Zijlstra, Josée M.; Eertink, Corinne
    Improved Risk Prediction in DLBCL By Combining Clinical and PET Features with Interim PET Assessment
    65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,
    In: Blood , Jg. 142 2023, Nr. Supplement 1, S. 1740 – 1741
    DOI (Open Access)